Literature DB >> 20143468

Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients.

Hua-Bang Zhou1, Hui Wang, Dong-Xun Zhou, Hao Wang, Qing Wang, Shan-Shan Zou, He-Ping Hu.   

Abstract

AIM: To investigate the prevalence, risk factors, and clinicopathologic characteristics of intrahepatic cholangiocarcinoma (ICC) in young patients.
METHODS: A retrospective analysis was performed in ICC patients referred to the Eastern Hepatobiliary Surgery Hospital in Shanghai, China. Among 317 consecutively enrolled patients, 40 patients were aged <or= 40 years (12.61%). We compared the risk factors and clinicopathologic characteristics of these patients (group I: n = 40) with those aged > 40 years (group II: n = 277).
RESULTS: Group I had distinct features compared with group II, including a low frequency of hepatolithiasis (P = 0.000); a high positive rate of serum hepatitis B surface antigen (P = 0.000) and hepatitis B virus (HBV)-associated cirrhosis (P = 0.038); a high frequency of alpha-fetoprotein (> 400 microg/L) (P = 0.011); a low frequency of carbohydrate antigen 19-9 (> 37 U/mL) (P = 0.017); and a high frequency of liver histological inflammation (P = 0.002). Although there was no significant difference between the two groups in regards to hepatic schistosomiasis, alcohol-associated cirrhosis and cirrhosis due to other causes (P > 0.05), they only occurred in the elderly group.
CONCLUSION: The risk factors are significantly different between young and elderly ICC patients. HBV and HBV-associated cirrhosis are the most important risk factors for young ICC patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143468      PMCID: PMC2825336          DOI: 10.3748/wjg.v16.i7.881

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.

Authors:  N Chalasani; A Baluyut; A Ismail; A Zaman; G Sood; R Ghalib; T M McCashland; K R Reddy; X Zervos; M A Anbari; H Hoen
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization.

Authors:  L Wilkens; M Bredt; P Flemming; J Klempnauer; H Heinrich Kreipe
Journal:  J Pathol       Date:  2000-09       Impact factor: 7.996

Review 5.  Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology.

Authors:  Kunio Okuda; Yasuni Nakanuma; Masaru Miyazaki
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

Review 6.  The epidemiology of cholangiocarcinoma.

Authors:  Yasser Shaib; Hashem B El-Serag
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

7.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 8.  Liver fluke-associated cholangiocarcinoma.

Authors:  P Watanapa; W B Watanapa
Journal:  Br J Surg       Date:  2002-08       Impact factor: 6.939

9.  Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening.

Authors:  C-M Lam; A O O Chan; P Ho; I O-L Ng; C M Lo; C L Liu; R T P Poon; S T Fan
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

10.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  4 in total

1.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

2.  Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Authors:  Ya-yong Li; Hao Li; Pin Lv; Gang Liu; Xiao-rong Li; Bu-ning Tian; Dao-jin Chen
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

Review 3.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

Review 4.  Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Seogsong Jeong; Ying Tong; Meng Sha; Jinyang Gu; Qiang Xia
Journal:  Oncotarget       Date:  2017-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.